Shandrea Rodriguez
Family · Providence, RINPI 1629278379
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 461 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 8.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $4,735 and has fallen 99.0% since, to $47 in 2023. Among family clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 461 payments — averaging $16.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$682
- AbbVie$675
- Novo Nordisk$673
- AstraZeneca$528
- Collegium Pharmaceutical, Inc.$521
- GSK$505
- plus $4K from 31 others
What the payments were for
- Food & beverage$7,695100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 46 | $682 |
| AbbVie | 30 | $675 |
| Novo Nordisk | 39 | $673 |
| AstraZeneca | 33 | $528 |
| Collegium Pharmaceutical, Inc. | 44 | $521 |
| GSK | 28 | $505 |
| Avanir Pharmaceuticals, Inc. | 29 | $466 |
| Teva Pharmaceuticals USA, Inc. | 17 | $366 |
| Nestle Healthcare Nutrition Inc. | 18 | $354 |
| Boehringer Ingelheim | 15 | $302 |
| Johnson & Johnson | 16 | $254 |
| Daiichi Sankyo Inc. | 20 | $210 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $195 |
| Mylan Specialty L.p. | 10 | $195 |
| Biohaven Pharmaceuticals, Inc. | 11 | $171 |
| Amgen | 9 | $164 |
| Kowa Pharmaceuticals America, Inc. | 12 | $143 |
| Lundbeck LLC | 9 | $140 |
| Novartis | 8 | $134 |
| Lilly USA, LLC | 7 | $121 |
| Eisai Inc. | 4 | $107 |
| E.r. Squibb & Sons, L.L.C. | 6 | $107 |
| Merck | 7 | $97 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $90 |
| Amarin Pharma, Inc. | 4 | $78 |
| Astellas Pharma US Inc | 4 | $70 |
| Jazz Pharmaceuticals Inc. | 3 | $59 |
| Bayer | 3 | $48 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $41 |
| Almatica Pharma LLC | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Antares Pharma, Inc. | 2 | $33 |
| Bausch Health US, LLC | 1 | $20 |
| CMP Pharma, Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Exact Sciences | 1 | $18 |
| Sun Pharmaceutical Industries Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QULIPTA$140
How this compares
$7,695 in reported general payments places this provider in the 95th percentile of 457 family providers in Rhode Island.
Other family in Providence
- Jeannie-Mae DurfeeProvidence$8K
- Colleen FullertonProvidence$8K
- Abbey Barkley DavisProvidence$7K
- Inna YakirevichProvidence$7K
- Dennis RotondiProvidence$5K
- Michael MoylanProvidence$5K
- Breanne St MartinProvidence$4K
- Caroline KinneyProvidence$4K
- Vanessa LopezProvidence$4K
- Bridget FitzgibbonProvidence$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.